Seeding trials and the subordination of science

Archives of Internal Medicine

Volumn 171, Issue 12, 2011, Pages 1107-1108

  Alexander, G Caleb ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN; ROFECOXIB;

BIOMEDICINE; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); DRUG APPROVAL; DRUG MARKETING; FOOD AND DRUG ADMINISTRATION; MEDICAL LIABILITY; MEDICAL RESEARCH; NOTE; PRESCRIPTION; PRIORITY JOURNAL; QUALITY CONTROL;

AMINES; ANTICONVULSANTS; CLINICAL TRIALS AS TOPIC; CONFLICT OF INTEREST; CYCLOHEXANECARBOXYLIC ACIDS; GAMMA-AMINOBUTYRIC ACID; HUMANS;

EID: 79960121147     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2011.232     Document Type: Note

References (9)

1. Moses HI III, Dorsey ER, Matheson DHM, Thier SO. Financial anatomy of biomedical research. JAMA. 2005;294(11):1333-1342. (Pubitemid 41345812)
2. Lexchin J. Those who have the gold make the evidence: how the pharmaceutical industry biases the outcomes of clinical trials of medications. Sci Eng Ethics. 2011.
3. Hill KP, Ross JS, Egilman DS, Krumholz HM. The ADVANTAGE seeding trial: a review of internal documents. Ann Intern Med. 2008;149(4):251-258.
4. Sox HC, Rennie D. Seeding trials: just say "no." Ann Intern Med. 2008;149(4): 279-280.
5. Krumholz SD, Egilman DS, Ross JS. Study of Neurontin: Titrate to Effect, Profile of Safety (STEPS) trial: a narrative account of a gabapentin seeding trial. Arch Intern Med. 2011;171(12):1100-1107.
6. Giacomini MK, Cook DJ; Evidence-Based Medicine Working Group. Users' guides to the medical literature, XXIII: qualitative research in health care A: are the results of the study valid? JAMA. 2000;284(3):357-362. (Pubitemid 30469863)
7. Greenland P, Lloyd-Jones D. Critical lessons from the ENHANCE trial. JAMA. 2008;299(8):953-955. (Pubitemid 351397071)
8. Alexander GC, Gallagher SA, Mascola A, Moloney RM, Stafford RS. Increasing off-label use of antipsychotic medicines, 1995-2008. Pharmacoepidemiol Drug Saf. 2011;20(2):177-184. doi:10.1002/pds.2082.
9. Andersen M, Kragstrup J, Søndergaard J. How conducting a clinical trial affects physicians' guideline adherence and drug preferences. JAMA. 2006;295 (23):2759-2764.